What is Alembic?
Alembic LLC operates at the intersection of neurovascular science and clinical engineering. By developing specialized medical technologies, the firm provides healthcare institutions with the tools necessary to improve patient outcomes in complex neurological procedures. The company's market position is defined by its commitment to rigorous clinical standards and the pursuit of novel therapeutic interventions. As a key player in the California biotech ecosystem, Alembic focuses on bridging the gap between laboratory innovation and bedside application, ensuring that healthcare providers have access to the most effective neurovascular tools available in the modern medical market.
How much funding has Alembic raised?
Alembic has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in Alembic
PPP
Public-Private Partnership
What's next for Alembic?
With this major enterprise-level funding, Alembic is poised to transition into a more aggressive phase of product commercialization and clinical validation. The strategic allocation of these resources will likely prioritize the expansion of their neurovascular product pipeline and the strengthening of their institutional partnerships. By leveraging this capital, the company aims to scale its operational capacity to meet the increasing demand for high-precision medical devices. Future growth will be contingent upon the successful navigation of regulatory pathways and the continued adoption of their technology by leading neurovascular centers, solidifying their role as a critical provider in the global healthcare infrastructure.
See full Alembic company page
